Vima LLC
BMY icon

Vima LLC’s Bristol-Myers Squibb BMY Stock Holding History

Vima LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.9K Hold
190
– – 0.01% 243
2026
Q2 		$10.9K Buy
+190
New +$10.9K 0.01% 267
2024
Q2 		– Sell
-190
Closed -$10.3K – 109
2024
Q1 		$10.3K Hold
190
– – 0.01% 229
2023
Q4 		$9.7K Buy
+190
New +$10K 0.02% 246

Other funds holding BMY

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Vima LLC's BMY Position: Q3 2026 in Review

Vima LLC held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 190 shares worth $11.9K. The position accounts for 0.01% of the portfolio, ranked #243.

Vima LLC first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. 1,133 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Vima LLC held 190 shares of Bristol-Myers Squibb worth $11.9K as of Q3 2026.
  • Vima LLC left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.01% of Vima LLC's portfolio in Q3 2026, its #243 holding.
  • Vima LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
  • 1,133 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Vima LLC's 13F filing for Q3 2026, filed 23 Oct 2026.